A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis ... we believe that there are instructive parallels between the biology ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

The child’s grandmother, who would care for him, also had tuberculosis (TB). In an attempt to protect the newborn from the disease, doctors gave him an oral dose of what was later named Bacille ...

Bacillus Calmette-Guérin (BCG) vaccine – named for its developers – contains inactivated mycobacteria that infect cattle and remains the only vaccination strategy against the infection in humans.

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

But the vaccine’s protection wanes with age, and the pathogen can infect adolescents and adults, causing a lung disease characterized by a persistent, sometimes bloody cough. Researchers aren’t sure ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...